PHOTOBIOLOGY OF VITAMIN D
PHOTOBIOLOGY OF VITAMIN D
批准号:
6206417
负责人:
MICHAEL F HOLICK
金额:
$0.49万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2000-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Multiple sclerosis (MS) is a T-cell mediated autoimmune disease of
the central nervous system (CNS). Much research related to the
immunological aspects of MS has focused on defining the nature of the
antigen(s) against which the immune response is generated and the
molecule(s) responsible for presentation of these antigens. For many
years, the dogma has been that T-cells recognize peptide antigens
presented in the context of M11C molecules and substantial research
has defined peptide antigens that may contribute to the pathogenesis
of MS. Recently, it hasbeen shown that molecules of the CD1 family
can act as restriction elements in lipid antigen presentations to
specialized subsets of T-cells suggesting that the spectrum of
antigens to which T-cells respond may be broader than previously
thought. Studies on the identification of these antigens have thus
far been directed only to bacterial components. CD1 glycoproteins are
cell surface molecules, noncovalently linked to beta2-microglobulin
and structurally related to major histocompatibility (M11C) antigens.
The CD I family includes CD I a, b and c proteins, products of
separate genes that all map to chromosome 1, having molecular masses
of 49, 45, and 43 kDa respectively. They are found on all cortical
thymocytes, but not on circulating T-cells or monocytes, and are
differentially expressed by subpopulations of dendritic cells,
Langerhans cells (CDI a and CD I c), subsets of B-cells (CD I c),
certain T-cell leukemias, and tissue macrophages in some inflammatory
lesions. In the brain, CD I a has been reported on microglia by some
investigators, but not others. Battistini et al.. have shown that
CDlb, is expressed in active MS lesions. Since lipids, particularly
glycolipids, are a major component of the myelin membrane it is
reasonable to consider that lipids may be involved in the
immunopathology of MS. The immune response would include CD1
molecules presenting lipid antigens to specialized populations of
T-cells. To test this hypothesis, the first step is to isolate and
characterize a purified lipid antigen that elicits a T-cell response.
Recent work has suggested that the glycolipids that elicit the most
response contain unusual fatty acids and long chain bases. Therefore,
it is important to find if unusual fatty acids or long chain bases are
expressed in MS tissues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHOTOBIOLOGY OF VITAMIN D
-
批准号:6345222
-
项目类别:
-
资助金额:$0.49万
-
财政年份:2000
-
负责人:MICHAEL F HOLICK
-
依托单位:
PHOTOBIOLOGY OF VITAMIN D
-
批准号:6478946
-
项目类别:
-
资助金额:$5.36万
-
财政年份:2000
-
负责人:MICHAEL F HOLICK
-
依托单位:
VITAMIN D3 FOR PSORIASIS
-
批准号:6306763
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1999
-
负责人:MICHAEL F HOLICK
-
依托单位:
TOPICAL 1,25 VITAMIN D3 IN CHILDREN WITH PSORIASIS
-
批准号:6117215
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1998
-
负责人:MICHAEL F HOLICK
-
依托单位:
VITAMIN D3 FOR PSORIASIS
-
批准号:6117211
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1998
-
负责人:MICHAEL F HOLICK
-
依托单位:
HEXAFLUORO 1 ALPHA 25 DIHYDROXYVITAMIN D3 & DOVONEX FOR TREATING PSORIASIS
-
批准号:6264934
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1998
-
负责人:MICHAEL F HOLICK
-
依托单位:
TOPICAL HEXA-FLUORO 1,25-DIHYDROVITAMIN D3 IN TREATING PSORIASIS
-
批准号:6117220
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1998
-
负责人:MICHAEL F HOLICK
-
依托单位:
VITAMIN D AND BONE STATUS IN THE ELDERLY
-
批准号:6233983
-
项目类别:
-
资助金额:$10.07万
-
财政年份:1997
-
负责人:MICHAEL F HOLICK
-
依托单位:
EVALUATION OF TOPICAL 24 EPI 1,25 DIHYDROXYVITAMIN D2
-
批准号:6248479
-
项目类别:
-
资助金额:$3.17万
-
财政年份:1997
-
负责人:MICHAEL F HOLICK
-
依托单位:
VITAMIN D3 FOR PSORIASIS
-
批准号:6278406
-
项目类别:
-
资助金额:$2.92万
-
财政年份:1997
-
负责人:MICHAEL F HOLICK
-
依托单位:
VITAMIN D3 FOR PSORIASIS
-
批准号:6248461
-
项目类别:
-
资助金额:$3.17万
-
财政年份:1997
-
负责人:MICHAEL F HOLICK
-
依托单位:
EFFICACY OF 1,25 DIHYDROXYVITAMIN D3 IN CHILDREN WITH PSORIASIS
-
批准号:6248466
-
项目类别:
-
资助金额:$3.17万
-
财政年份:1997
-
负责人:MICHAEL F HOLICK
-
依托单位:
FAT CONTENT EFFECTS ON BIOAVAILABILITY OF VITAMIN D IN MILK
-
批准号:6278416
-
项目类别:
-
资助金额:$2.92万
-
财政年份:1997
-
负责人:MICHAEL F HOLICK
-
依托单位:
COMPARISON OF CALCIPOTRIENE IN TREATING PSORIASIS
-
批准号:6248472
-
项目类别:
-
资助金额:$3.17万
-
财政年份:1997
-
负责人:MICHAEL F HOLICK
-
依托单位:
TOPICAL 1,25 VITAMIN D3 IN CHILDREN WITH PSORIASIS
-
批准号:6278410
-
项目类别:
-
资助金额:$2.92万
-
财政年份:1997
-
负责人:MICHAEL F HOLICK
-
依托单位:
DAB389IL-2 IN PATIENTS WITH MODERATE TO SEVERE PLAQUE TYPE PSORIASIS
-
批准号:6248478
-
项目类别:
-
资助金额:$3.17万
-
财政年份:1997
-
负责人:MICHAEL F HOLICK
-
依托单位:
TOPICAL HEXA-FLUORO 1,25-DIHYDROVITAMIN D3 IN TREATING PSORIASIS
-
批准号:6248480
-
项目类别:
-
资助金额:$3.17万
-
财政年份:1997
-
负责人:MICHAEL F HOLICK
-
依托单位:
TOPICAL HEXA-FLUORO 1,25-DIHYDROVITAMIN D3 IN TREATING PSORIASIS
-
批准号:6278415
-
项目类别:
-
资助金额:$2.92万
-
财政年份:1997
-
负责人:MICHAEL F HOLICK
-
依托单位:
VITAMIN D3 FOR PSORIASIS
-
批准号:5220608
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL F HOLICK
-
依托单位:--
VITAMIN D AND BONE STATUS IN THE ELDERLY
-
批准号:5204391
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL F HOLICK
-
依托单位:--
海外基金